ClinicalTrials.Veeva

Menu

The Validity and Reliability of the Turkish Version of the Combined Index of Severity of Fibromyalgia

E

European University of Lefke

Status

Enrolling

Conditions

Fibromyalgia

Treatments

Other: Perceptive rehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT03800199
ETK00-2018-0281

Details and patient eligibility

About

The aim of the investigator's study is to determine the validity and reliability of the Turkish version of the Combined Index of Severity (ICAF) in Turkish patients with Fibromyalgia Syndrome (FMS).

Full description

The original form of the Combined Index of Severity of Fibromyalgia (ICAF) will be translated into Turkish by two Turkish mother tongue translators who also speak English in advanced level. Then these translations will be combined into one translation and translated back to English. These translations will send to 7 different health professions who had experience working with FMS patients. The pre-final version will be composed and tested on a group of patients with FMS. If necessary, readjustments will be made, and the final version will be investigated in FMS patients. Acceptability was assessed in terms of refusal rate, rates of missing responses, and administration time. Reliability was assessed using Cronbach's alpha and test-retest assessments. Re-test assessments will be conducted after one week from first assessment. Content validity was assessed by examining the floor and ceiling effects and skew of the distributions. Convergent and divergent validity was assessed by examining the Pearson's correlation coefficients. In addition, the confirmatory factor analysis will be done to evaluate the validity of ICAF. Responsiveness was determined by examining effect size (ES), standardized response means (SRM) and P values generated using Wilcoxon's test.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Having a Fibromyalgia diagnosis according to Wolfe et al. (2016) criteria.
  • Feeling Fibromyalgia symptoms last 3 mounts

Exclusion criteria

  • Having physical and functional problems with FMS
  • Having a diagnosis of chronic pain other than FMS,
  • Using medicine other than simple analgesics,
  • History of cardiovascular or pulmonary diseases
  • Can not read and write in Turkish language

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

200 participants in 1 patient group

Perceptive Rehabilitation (PR-group)
Experimental group
Description:
Perceptive rehabilitation group will receive a treatment that, as described by on Paolucci et al. (2015). This treatment will include small latex cones with different resistance. In each session there will be over 100 cones will be placed on a rigid wood with using elastic strips. The patient will be asked to lie down supine on the material. Patients weigh will create pressure and reaction force to his/her body. Treatments will be 2 times a week till 8 weeks. There will be in total 16 sessions.
Treatment:
Other: Perceptive rehabilitation

Trial contacts and locations

1

Loading...

Central trial contact

Emine H. Tüzün, Prof. Dr.; Beraat Alptug, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems